Table 4. Association of SNPs of RB1 and CCND1 gene with brain tumor risk based on genetic models.
| Genotype/Allele | Model | OR (95% CI) | P-value |
|---|---|---|---|
| RB1 gene | |||
| rs137853294 | |||
| CC vs CT + TT | Dominant | 1.62 (1.13–2.33) | 0.008† |
| TT vs CC + CT | Recessive | 1.58 (0.77–3.26) | 0.21 |
| T vs C | Additive | 1.50 (1.11–2.01) | 0.007† |
| rs121913300 | |||
| CC vs CT + TT | Dominant | 3.78 (2.12–6.73) | <0.0001**** |
| TT vs CC + CT | Recessive | 20.48 (2.72–154.21) | 0.003† |
| T vs C | Additive | 1.56 (1.22–2.01) | 0.0005‡ |
| CCND1 gene | |||
| rs614367 | |||
| CC vs CT + TT | Dominant | 1.77 (1.24–2.52) | 0.002† |
| TT vs CC + CT | Recessive | 4.88 (1.39–17.21) | 0.01* |
| T vs C | Additive | 1.65 (1.23–2.22) | 0.0007‡ |
| rs498136 | |||
| GG vs GT + TT | Dominant | 1.38 (0.96–1.99) | 0.08 |
| TT vs GG +GT | Recessive | 8.23 (1.02–66.31) | 0.047* |
| T vs G | Additive | 1.27 (0.97–1.66) | 0.08 |